← FDA DRUG APPROVALS

FDA ANDA · ANDA064055

NEOMYCIN SULFATE AND DEXAMETHASONE SODIUM PHOSPHATE

Sponsor: BAUSCH AND LOMB

APPLICATION
ANDA064055
TYPE
ANDA
ORIGINAL APPROVAL
1995-10-30
LATEST ACTION
1995-10-30
ROUTE
OPHTHALMIC
DOSAGE FORM
SOLUTION/DROPS
MARKETING STATUS
Discontinued

Products

NEOMYCIN SULFATE AND DEXAMETHASONE SODIUM PHOSPHATEDiscontinued
DEXAMETHASONE SODIUM PHOSPHATE EQ 0.1% PHOSPHATE, NEOMYCIN SULFATE EQ 3.5MG BASE/ML · SOLUTION/DROPS · OPHTHALMIC

Approval history

1995-10-30OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →